Press release
Personalized Medicine Market Forecast 2026-2036: Market to Reach USD 779.4 Billion by 2036 at 6.4% CAGR
Read Full Report:https://www.futuremarketinsights.com/reports/personalized-medicine-market
Market snapshot: global market 2026 - 2036
Market size 2026? USD 419.1 billion.
Market size 2036? USD 779.4 billion.
CAGR? 6.4%.
Leading product segment(s) and shares: Companion diagnostics and targeted therapeutics hold the largest combined share; diagnostics segment dominates due to its critical role in identifying biomarkers, while therapeutics see high growth from targeted drug development.
Leading application and share: Oncology accounts for the majority of personalized medicine revenue.
Leading end use: Hospitals and clinics lead as primary delivery points for advanced diagnostics and targeted therapies.
Key growth regions: Asia Pacific, led by India and China; North America remains dominant by value.
Top companies: Illumina Inc., Asuragen Inc., Genentech, Inc., Abbott Laboratories, Roche Holding AG, Thermo Fisher Scientific, Danaher Corporation, Guardant Health, Foundation Medicine, Myriad Genetics, Exact Sciences, Tempus AI.
The personalized medicine market is on a steady upward trajectory, building from USD 393.9 billion in 2025 to projected values of USD 474.5 billion in 2028, USD 537.1 billion in 2030, USD 571.5 billion in 2031, USD 647.0 billion in 2033, and USD 732.5 billion in 2035. This year-over-year path highlights the compounding impact of technological advancements and regulatory support in the personalized medicine market.
Why the Market is Growing
The personalized medicine market is expanding due to companion diagnostic mandates from the FDA and EMA, which tie drug approvals to matched testing and create parallel revenue streams. Liquid biopsy adoption is transforming oncology monitoring from periodic imaging to real-time molecular surveillance. Pharmacogenomics integration into electronic health records is broadening prescriber adoption beyond oncology into cardiology and psychiatry.
Segment Spotlight
Product Type
The diagnostics segment dominates the personalized medicine market because of its essential function in pinpointing biomarkers, genetic mutations, and patient-specific disease profiles, especially in oncology, rare diseases, and pharmacogenomics. The therapeutics segment experiences high growth driven by advancements in targeted drug development, gene therapy, and immunotherapy.
Application
Oncology accounts for the majority of revenue in the personalized medicine market, fueled by tumor profiling and biomarker therapies that identify the most effective and least toxic regimens based on genomic profiles. This dominance extends opportunities for pharmaceutical companies to expand pipelines with declining genomic sequencing costs and companion diagnostics.
End Use
The hospitals segment holds a broad portion of the personalized medicine market as it serves as the key hub for delivering advanced diagnostics, genomic tests, and targeted therapies, particularly in oncology, cardiology, and rare diseases. Specialized genomics centers command a significant share through their expertise in advanced genomic sequencing, bioinformatics, and multi-omics, supporting clinical diagnostics for complex conditions.
Drivers, Opportunities, Trends, Challenges
Companion diagnostic mandates and regulatory pull are key drivers in the personalized medicine market, with the FDA approving 12 personalized medicines in 2024, representing 34% of new approvals. Cost deflation in sequencing, now below USD 200 per test, enables wider adoption, while pharma-diagnostics convergence through partnerships accelerates precision medicine scaling.
Opportunities arise from growth investments in oncology and rare disease treatments, where tumor profiling and gene therapies revolutionize care for genetic conditions. Declining sequencing costs and companion diagnostics open pathways for faster drug development, regulatory approvals, and reimbursement for targeted therapies, fostering market expansion globally.
Emerging trends include the integration of data analytics in personalized treatment, using machine learning to process genomic and clinical data for predictive plans, especially in cancer. Direct-to-consumer genetic testing is also rising, offering personalized health insights on disease risk and medication response, driving proactive preventive medicine.
Challenges involve the integration and secure management of diverse data sources like genomics, EHRs, and lifestyle information, hindered by silos in health systems and interoperability issues. This compromises clinical views and raises privacy concerns, while the gap between diagnostic capabilities and available therapies creates value chain imbalances.
Country Growth Outlook (CAGR)
Country
CAGR (2026-2036)
China
7.6%
India
8.2%
Germany
5.8%
UK
5.5%
USA
6.2%
Brazil
6.8%
(Note: France data not specified in analysis.)
Competitive Landscape
The competitive outlook in the personalized medicine market emphasizes predictive analytics and multi-omics approaches to boost diagnostic precision and therapeutic targets. Companies are forming affiliations with biotechnology firms, hospitals, and genomics laboratories to strengthen their presence. Regulatory approvals favor companion diagnostics and targeted therapies, while rapid sequencing technologies and digital health solutions drive innovation. Market share leaders include Illumina Inc. (33.6% to 38.5%), Asuragen Inc. (20.4% to 22.6%), Genentech, Inc. (15.1% to 17.2%), and Abbott Laboratories (4.6% to 6.8%). Recent developments feature SOPHiA GENETICS expanding its AI platform in February 2026, Gilead Sciences advancing antibody-drug conjugates, and Eli Lilly progressing its oral GLP-1 candidate. Other key players encompass Exact Sciences Corporation, Biogen International, Exagen Inc., Genelex Corporation, Precision Biologics, Inc., QIAGEN, Celera Diagnostics LLC, and Dako A/S.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1511
Get Access of Report Sample:https://www.futuremarketinsights.com/reports/sample/rep-gb-1511
Scope of the Report
Quantitative Units: USD 419.1 billion (2026) to USD 779.4 billion (2036), at a CAGR of 6.4%.
Market Definition: Products, technologies, and services that tailor medical treatment to individual patient characteristics, spanning genomic diagnostics, pharmacogenomic testing, companion diagnostics, biomarker-guided therapeutics, and precision digital health platforms.
Product Type Segmentation: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness.
End User Segmentation: Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Others.
Regions Covered: North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa.
Key Companies Profiled: Roche Holding AG, Illumina Inc., Thermo Fisher Scientific, Danaher Corporation, Abbott Laboratories, Guardant Health, Foundation Medicine, Myriad Genetics, Exact Sciences, Tempus AI.
Forecast Period: 2026 to 2036.
FAQ
What market intelligence does this provide for strategic decision-making? It offers insights across diagnostics, therapeutics, and precision care delivery in the personalized medicine market.
What is the market size estimation and forecast? The personalized medicine market includes 10-year revenue forecasts from 2026 to 2036.
What growth opportunities are mapped? Opportunities are detailed across personalized diagnostics, targeted therapeutics, medical care, and nutrition segments.
Are segment and regional revenue forecasts included? Yes, the report provides segmental breakdowns and regional forecasts for the personalized medicine market.
What competition strategy assessments are covered? Assessments include diagnostics-therapeutics integration models and AI-driven pathology platforms.
How does it analyze regulatory impact? It covers FDA companion diagnostic approvals, EMA guidelines, and Asia Pacific genomic testing frameworks.
What about reimbursement landscape? Tracking is provided across Medicare, NHS, and major commercial payers in the personalized medicine market.
In what formats is the market report delivered? Delivery includes PDF, Excel, PPT, and interactive dashboard formats.
Explore More Related Studies Published by FMI Research:
Pediatric Non-invasive Wearables Market: https://www.futuremarketinsights.com/reports/pediatric-non-invasive-wearables-market
Mobile Diagnostic Sealed MRI Magnets Market: https://www.futuremarketinsights.com/reports/mobile-diagnostic-sealed-mri-magnets-market
Children Appetite Stimulant Market: https://www.futuremarketinsights.com/reports/children-appetite-stimulant-market
AI Oncology Vibe CT Scanners Market: https://www.futuremarketinsights.com/reports/ai-oncology-vibe-ct-scanners-market
Single Use Pump Market: https://www.futuremarketinsights.com/reports/single-use-pump-market
Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi
Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Personalized Medicine Market Forecast 2026-2036: Market to Reach USD 779.4 Billion by 2036 at 6.4% CAGR here
News-ID: 4401357 • Views: …
More Releases from Future Market Insights
Ambroxol HCL Market to Reach USD 3.37 Million by 2036 as Rising Demand for Respi …
NEWARK, Del., July 20, 2026 - The Ambroxol HCL Market is expected to witness steady growth as the global healthcare industry continues to experience sustained demand for respiratory therapies used in the treatment of cough, mucus clearance, and other respiratory tract disorders. According to Future Market Insights (FMI), the market is projected to grow from USD 2.58 million in 2026 to USD 3.37 million by 2036, registering a 2.72% CAGR…
Neuro-Restoration Spinal Cord Injury Venture Capital Market on Track for USD 356 …
NEWARK, Del., July 20, 2026 - The Neuro-Restoration Spinal Cord Injury Venture Capital Market is poised for remarkable expansion as global healthcare investors increase funding for neurotechnology, regenerative medicine, and spinal cord injury restoration therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 45.0 million in 2026 to USD 356.7 million by 2036, registering a robust 23.0% CAGR during the forecast period. Rising venture…
Modulated Aspiration Devices Market Forecast to Hit USD 430.0 Million by 2036 wi …
NEWARK, Del., July 20, 2026 - The Modulated Aspiration Devices Market is expected to witness significant growth as healthcare providers increasingly adopt advanced aspiration technologies to improve clot removal efficiency and patient outcomes in neurovascular and cardiovascular interventions. According to Future Market Insights (FMI), the market is projected to grow from USD 185.0 million in 2026 to USD 430.0 million by 2036, registering a 8.8% CAGR during the forecast period.…
Portable Ultrasound Workflow Guidance Software Market on Track for USD 160.0 Mil …
NEWARK, Del., July 20, 2026 - The Portable Ultrasound Workflow Guidance Software Market is poised for strong growth as healthcare providers increasingly adopt AI-enabled imaging solutions to improve bedside diagnostics, workflow efficiency, and clinical decision-making. According to Future Market Insights (FMI), the market is projected to grow from USD 60.0 million in 2026 to USD 160.0 million by 2036, registering a 10.3% CAGR during the forecast period. Rising adoption of…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population?
The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
